Lexaria Bioscience Corp (LEXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
(Values in U.S. thousands)
| 05-2026 | 02-2026 | 11-2025 | 08-2025 | 05-2025 | |
| Sales | 0 | 20 | 0 | 174 | 174 |
| Gross Profit | N/A | 20 | 0 | 174 | 174 |
| Operating Expenses | 1,994 | 1,472 | 1,574 | 2,863 | 3,924 |
| Operating Income | -1,994 | -1,452 | -1,574 | -2,689 | -3,750 |
| Other Income | 1 | 2 | -22 | -9 | -40 |
| Pre-tax Income | -1,993 | -1,450 | -1,596 | -2,697 | -3,791 |
| Income Tax | 0 | 3 | 2 | N/A | N/A |
| Net Income Continuous | -1,993 | -1,453 | -1,598 | -2,697 | -3,791 |
| Minority Interests | -2 | -3 | -3 | -1 | -2 |
| Net Income | $-1,991 | $-1,450 | $-1,595 | $-2,696 | $-3,789 |
| EPS Basic Total Ops | -0.08 | -0.06 | -0.07 | -0.14 | -0.21 |
| EPS Basic Continuous Ops | -0.08 | -0.06 | -0.07 | -0.14 | -0.21 |
| EPS Diluted Total Ops | -0.08 | -0.06 | -0.07 | -0.14 | -0.21 |
| EPS Diluted Continuous Ops | -0.08 | -0.06 | -0.07 | -0.14 | -0.21 |
| EPS Diluted Before Non-Recurring Items | -0.08 | -0.06 | -0.07 | -0.13 | -0.21 |
| EBITDA(a) | $-1,975 | $-1,433 | $-1,557 | $-2,667 | $-3,720 |